| Literature DB >> 25477775 |
Julia Jacobs1, Antonia Menzel2, Georgia Ramantani3, Katharina Körbl2, Jakob Assländer4, Andreas Schulze-Bonhage3, Jürgen Hennig4, Pierre LeVan4.
Abstract
INTRODUCTION: EEG-fMRI detects BOLD changes associated with epileptic interictal discharges (IED) and can identify epileptogenic networks in epilepsy patients. Besides positive BOLD changes, negative BOLD changes have sometimes been observed in the default-mode network, particularly using group analysis. A new fast fMRI sequence called MREG (Magnetic Resonance Encephalography) shows increased sensitivity to detect IED-related BOLD changes compared to the conventional EPI sequence, including frequent occurrence of negative BOLD responses in the DMN. The present study quantifies the concordance between the DMN and negative BOLD related to IEDs of temporal and extra-temporal origin.Entities:
Keywords: EEG-fMRI; default mode; epileptic spikes; fast fMRI; refractory epilepsy
Year: 2014 PMID: 25477775 PMCID: PMC4235409 DOI: 10.3389/fnins.2014.00335
Source DB: PubMed Journal: Front Neurosci ISSN: 1662-453X Impact factor: 4.677
Clinical information.
| 1 | 26 | m | 7y | Structural | CPS | Hypothalamic harmatoma | LEV, OXC, LCM |
| 2 | 36 | m | 7y | Structural TLE | CPS | MTS R | LTG, LCM |
| 3 | 17 | m | 13y | Unclear | SPS/CPS GTCS | Normal | LTG, OXC |
| 4 | 17 | f | 16y | Structural TLE | CPS | Unclear mass in the L superior T gyrus | OXC |
| 5 | 27 | m | 11y | Structural FLE | SPS/CPS GTCS | Surgical cavity F L | LEV, OXC |
| 6 | 12 | m | 9y | Structural FLE | CPS | Caveroma F R | none |
| 7 | 9 | m | 4y | Structural FLE | SPS/CPS | Extensive R polymicrogyria | LEV, VPA |
| 8 | 28 | f | 11y | FLE of unclear origine | SPS/CPS GTCS | Unclear lesion F R, including insular cortex. | LTG, LCM |
| 9 | 71 | m | 70y | Structural TLE | CPS | Cystic tumor mesio-temporal L | VPA |
| 10 | 31 | f | 31y | TLE | CPS | Normal | OXC |
| 11 | 60 | m | 40y | Structural TLE | CPS | Defect /sclerosis T pole L. | OXC |
| 12 | 23 | m | 14y | Structural TLE | SPS, CPS | FCD T L | LTG |
| 13 | 40 | f | 23y | Bilateral TLE | CPS, GTCS | Malrotation HC R | LTG |
| 14 | 14 | f | 7y | Structural FLE | CPS | FCD F R | VPA, OXC |
| 15 | 16 | m | 1y | Structural PLE | CPS | Tuberous sclerosis | LEV, ZNS |
AED, antiepileptic drugs; C, central; CPS, complex partial seizures; FCD, focal cortical dysplasia; f, female; F, frontal; FLE, frontal lobe epilepsy; GTCS, generalized tonic clonic seizures; HC, hippocampus; m, male; L, left; LCM, lacosamide; LEV, levetirazetam; LTG, lamotrigine; O, occipital; OXC, oxcarbazepin; P, parietal; PLE, parietal lobe epilepsy; R, right; SPS, simple partial seizures; y, years; T, temporal; TLE, temporal lobe epilepsy; VPA, valproate; ZNS, zonisamide.
Summary of IED types and overlap between DMN and negative BOLD.
| 1 | 1 | TP right | T | 6 | 11 | 6 |
| 2 | 2 | F T right | T | 4 | 12 | 14 |
| 3 | T right | T | 1 | 19 | 9 | |
| 3 | 4 | F right | EX-T | 7 | 10 | 5 |
| 5 | PO Left | EX-T | 2 | 15 | 6 | |
| 6 | F left | EX-T | 13 | 11 | 3 | |
| 4 | 7 | T right | T | 1 | 18 | 4 |
| 8 | P right | Ex-T | 2 | 21 | 7 | |
| 9 | F right | Ex-T | 3 | 9 | 6 | |
| 5 | 10 | C left | Ex-T | 46 | 17 | 5 |
| 11 | T left | T | 8 | 16 | 32 | |
| 12 | F pole left | Ex-T | 9 | 10 | 2 | |
| 13 | F right | Ex-T | 3 | 10 | 4 | |
| 6 | 14 | T left | T | 2 | 12 | 7 |
| 7 | 15 | F pole right | Ex-T | 1 | 0 | 0 |
| 16 | FP right | Ex-T | 1 | 24 | 2 | |
| 8 | 17 | F left | Ex-T | 3 | 3 | 2 |
| 18 | FP right | Ex-T | 21 | 4 | 5 | |
| 19 | T right | T | 2 | 5 | 0 | |
| 9 | 20 | F pole left | Ex-T | 2 | 6 | 5 |
| 21 | F left | Ex-T | 2 | 6 | 4 | |
| 22 | T right | T | 2 | 3 | 2 | |
| 10 | 23 | T right | T | 1 | 6 | 2 |
| 11 | 24 | FT left | T | 2 | 10 | 5 |
| 25 | CP right | Ex-T | 1 | 7 | 0 | |
| 12 | 26 | FT left | T | 10 | 10 | 14 |
| 13 | 27 | T right | T | 3 | 15 | 29 |
| 28 | P right | Ex-T | 12 | 14 | 2 | |
| 14 | 29 | F pole right | Ex-T | 1 | 21 | 13 |
| 15 | 30 | F pole right | Ex-T | 4 | 8 | 5 |
| Mean and SD | 11.2 ± 6.2 | 6.7 ± 8 | ||||
C, central; DMN, default mode network; Ex-T, extra-temporal; F, frontal, IED, interitcal epileptic discharge; P, parietal; pos, positive; neg, negative; SD, standard deviation; T, temporal.
Figure 1Average size of overlap in cubic-centimeters between the negative BOLD and DMN structures in temporal and extra-temporal IED. The average size of negative BOLD as well as the overlap is significantly larger for temporal than extra-temporal IED. (A) Average size areas covered by negative BOLD.
Figure 2Example of the overlap between negative BOLD responses and DMN regions. Patient # 2 had two different IED generated over the anterior and posterior region of temporal structures. DMN regions according to the AAL atlas are shown in red, negative BOLD in blue. (A) Shows the overlap for IED # 2 which occurred 4 times during the scan. 12% of the negative BOLD was located within the DMN and 14% of the DMN were covered by negative BOLD. (B) Shows the response to IED # 2 which only occurred once during the scan time. 19% of negative BOLD was located within DMN regions and 9% of DMN was covered by negative BOLD.
Figure 3Example of the overlap between negative BOLD responses and DMN regions. Patient # 13 had two different IED one generated over the right temporal and the other over the right parietal region. (A) Demonstrates that overlap for the temporal IED with 15% of the negative BOLD located within the DMN and 29% of the DMN covered by negative BOLD. In agreement with our findings the overlap is larger than in the parietal IED of the same patient even if the temporal IEDs only occurred 3 times, while the parietal time was seen 12 times during the measurement. (B) Shows the negative BOLD changes related to the parietal IED. 14% of the negative BOLD are located in the DMN region and 2% of the DMN are covered by negative BOLD.
Figure 4Percentage of overlap between negative BOLD and DMN structures. The percentage of DMN structures covered by negative BOLD is significantly higher in temporal than extra-temporal IED. Panel (A) display of the negative BOLD lying within regions of the DMN. Panel (B) display of the percentage of DMN covered by negative BOLD.